Načítá se...
Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
Tyrosine kinase inhibitors sunitinib and pazopanib are used as first-line agents in the treatment of metastatic renal cell carcinoma. Treatment-related toxicities have been described with both these drugs. This report describes a patient with metastatic renal carcinoma who developed trismus while be...
Uloženo v:
| Vydáno v: | Indian J Urol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5264200/ https://ncbi.nlm.nih.gov/pubmed/28197036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.194787 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|